
|Articles|March 15, 2004
Drug beneficial for those with or without Sj?gren's dry eye
Anaheim, CA-Cyclosporine 0.05% ophthalmic emulsion (Restasis, Allergan) provides similar, significant improvement in the signs and symptoms of dry eye in both patients with keratoconjunctivitis sicca (KCS) associated with autoimmune disease and in those with non-Sj?gren's KCS, said Scott M. Whitcup, MD, at the annual meeting of the American Academy of Ophthalmology.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approvals in 2025: What changed and why it matters for ophthalmologists
2
What changed in glaucoma care in 2025: Surgeon perspective
3
Achieving a new level of refractive precision: Surgical strategies
4
Global trial equity: How LMIC data is reshaping US ophthalmology research
5




